My #1 Bio/Medical (NASDAQ) Trading Secretly At $1

New MedTech NASDAQ Alert Arrives At 4:00PM Today

May 24th

Good Morning,

What if you could buy shares of Pfizer when it was a tiny, little-known company?

What is you could buy shares of Apple when it first went public?

With my scanners on full blast this morning, I’ve uncovered a new MedTech (medical technology) NASDAQ alert for this coming Tuesday morning.

With the long weekend ahead of us, I’m going to be delivering this company report right after today’s bell in the hopes that you’ll have multiple days to study up and prepare.

Stocks with medical technology ties surged 12%-21% from January through April 2019. Six of the fastest-growing stocks among them tacked on double-digit earnings growth over the past five year span.

Many analysts share that strength for MedTech stocks comes from an aging U.S. population plus innovation among device makers.

Meanwhile, MedTech companies usually avoid the same political obstacles that affect biotech and pharmaceutical stocks.

Knowing this vital industry/sector information, I’m in the opinion that this stock is undervalued and could be ready to burst.


When alerts and updates come out, you want to be the first to get them. This is how to get to the front of the line…

Make Sure You’re Signed To Free SMS Alert System – “This Way You Will Get The Alert First”

Step 1: Text the word “GOLD” to the number 71441 on your cell phone dial pad. Literally type in 71441 into your phone dial pad, then look for area on your phone saying “Send Message” and click Send.

Step 2: After you send it, you will immediately receive a confirmation message on your cell phone saying, “StockWireNews You’re Now Signed Up To Get My Stock Profiles Lightning Fast!


I’ll be in touch this afternoon with your full report. Talk again in a few hours.


Kai Parker


Discl.aimer: I am not a lice.nsed finan.cial adviser. All potential percentage gains are based on from the low to the high of day. StockWireNews full discl.aimer is to be read and fully understood before using StockWireNews website, or joining StockWireNews' email or text list. By viewing StockWireNews website and/or reading Stock Wire News email or text newsletter you are agreeing to StockWireNews full discl.aimer which can be read at Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention.